Pharmaceutical Executive November 9, 2023
A look into the potential effect of psychedelic drugs on various illnesses, such as mental health conditions.
There has been a growing interest in the potential of psychedelic medicines, with pharmaceutical companies heavily investing in integrating these agents into healthcare, with increasing support from various stakeholders and both parties in the U.S. Congress1. According to an article from Politico, psychedelics are gaining new resonance 56 years after psychologist Timothy Leary, PhD, urged 30,000 hippies in San Francisco’s Golden Gate Park to “turn on, tune in and drop out.” In modern times, psychedelic medicines have shown considerable promise in helping to heal intractable psychic wounds2.
Back in June, the FDA issued a new draft guidance to highlight fundamental considerations to researchers...
Today's Sponsors
Today's Sponsor